Avid Bioservices Inc (CDMO)

[entdoc]

Thanx y'all for the great discussion of PPHM's BavituxiMAB use along with focused irradiation for LungCA treatment. Undeniably, PPHM has not hesitated to get in the ring against the toughest CAs. Bavi-imaging and Bavi + irradiation is another vast aspect of anti-PS technology, another corporate department if you will. If we need something to focus attention, that is the PPHM department that will do it. And to finish off those stubborn surviving "core cancer [stem?] cells", those in the miasma of dying cancer cells in the tumor center, until armed Bavi- can carry the RAIodine to them, there is always PPHM's anti-TNT MAB, Cotara.
In regard to Bavi acting alone, it seems it has probably been established that Bavi alone has weak tumorcidal effect, but not a wallop, so stand-alone Bavi awaits much smaller and earlier cancers. Bavi is "double-fisted", and is capable of carrying a payload, but loading one fist of the MAB and leaving only one -PS site available for docking causes considerable loss of specificity for the loaded MAB missile. Certainly that, and more fully humanized Bavi hybrids are on the conceptual drawing boards. Agree with posters here who think there's a sizable crowd gathering on the sidelines. Because of PPHM management ethical communications in the past, I am inclined to side with the optimistic views expressed here so often of late.